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ABSTRACT 
 
Aim: To observe the variations in sympathetic response to laryngoscopy and intubation in patients without measures 
to attenuate sympathetic response. To study the effectiveness of lornoxicam in attenuating pressor response to 
laryngoscopy and intubation. Materials and Methods: A clinical comparative study of attenuation of sympathetic 
response to laryngoscopy and intubation was done posted for elective surgery. 60 cases are divided in to two groups 
30 in each group. Group-1 was Control group. In this group placebo i.e (Normal saline-4ml) was administered 30 
min before intubation. Group-2 was Lornoxicam group. In this group patients received lornoxicam 16mg 
intravenous 30 min before intubation to attenuate pressor response to laryngoscopy and intubation. Results: 
Sympathoadrenal response to direct laryngoscopy and tracheal intubation invariably results in increases in heart rate 
and elevation in mean arterial pressure. In some instances arrhythmias can be precipitated. These potentially harmful 
responses may prove to be detrimental in patient at risk. Many techniques and various drugs have been employed to 
attenuate these haemodynamic responses. No single drug or technique is totally satisfactory. Thus there is a need to 
find a simple efficient and reliably consistent method. The present study is a double blinded comparative study 
conducted in 60 patients belonging to ASA-I and II. One group received placebo(5ml of normal saline )and the other 
group received Lornoxicam 16mg intravenously half an hour before induction preoperatively. All cases were 
premedicated with oral diazepam 10mg the night before surgery. Inj Midazolam 0.05mg/kg IM and was 
administered 45 minutes before laryngoscoopy. Anaesthesia was induced with Inj thiopetone 5mg/kg IV. 
Succinylcholine was used for relaxation at a dose of 2mg/kg IV. Laryngoscopy and intubation was limited to 20 
seconds in all case. Anaesthesia was maintained with O2 (33%), N2O (67%), sevoflurane  and intermittent 
vecuronium 0.05 mg/kg IV and IPPV using Bain’s circuit. Hemodynamic parameters recorded include heart rate, 
systolic and diastolic blood pressure before induction, post induction and after 1,3,5 7 and 10 minutes from the onset 
of laryngoscopy. In the control group heart rate, systolic, diastolic and mean arterial blood pressures showed wide 
fluctuation, a maximal increase at 1 minute post laryngoscopy and returned gradually to basal values over 10 
minutes. In Lornoxicam group significant suppression of heart rate and blood pressure was observed when 
compared to control group which returned to baseline at the end of 10min. Conclusion: Lornoxicam  significantly 
attenuates the sympathetic response to laryngoscopy and tracheal intubation. 
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Introduction 
 
Endotracheal intubation has become an integral part of 
anaesthetic management and critical care since its 
description in 1921 by Rowbotham and Magili[1].In 
1940 Reid and Brace first described haemodynamic  
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response to laryngoscopy and intubation due to noxious 
stimuli[2].Evidence from laboratory data demonstrates 
that epipharyngeal and laryngopharyngeal stimulation 
augments cervical sympathetic activity in efferent 
fibres of the heart
3
. King et al. (1951) described the 
circulatory responses to laryngeal and tracheal 
stimulation following laryngoscopy and tracheal 
intubation as reflex sympathoadrenal stimulation[1-
3]Even though the elevation in blood pressure and 
heart rate due to laryngoscopy and intubation are brief, 
they may have detrimental effects in high risk patients 
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including myocardial infarction, cardiac failure, 
intracranial hemorrhage and increases in intracranial 
pressure
.
 Laryngoscopy and tracheal intubation induces 
changes in circulating catecholamine levels 
significantly. Norepinephrine, epinephrine and 
dopamine levels rise, but the raise in norepinephrine 
levels is consistently associated with elevation of blood 
pressure and heart rate[4]. Some authors infact 
consider the intubation period as one of the greatest 
risk phase in the surgical patients with coronary artery 
disease and patients with intracranial aneurysms. 
Although the response may be transient, it is 
invariable, significant, often persistent and of great 
concern[5].The techniques of laryngoscopy and 
tracheal intubation are not confined only to the 
operating room, but are also employed for non 
anaesthetic purposes. Few instances are diagnostic 
laryngoscopy, fibreoptic bronchoscopy, intubation may 
be required for  prevention of aspiration and protection 
of airway and during mechanical ventilation. All these 
procedures can also produce sympathetic responses and 
one should keep in mind that many of these patients are 
critically ill and at increased risk. Hence it is important 
to find an effective means of attenuating sympathetic 
responses to laryngoscopy and tracheal intubation. 
Many strategies have been advocated to minimise these 
hemodynamic adverse responses and aimed at different 
levels of the reflex arc[5]. Block of the peripheral 
sensory receptors and afferent input – topical 
application and infiltration of local anaesthetic to 
superior laryngeal nerve. Block of central mechanism 
of integration and sensory input – fentanyl, morphine 
etc. Block of efferent pathway and effector sites i.v. 
lignocaine, b blockers, calcium channel blockers, 
hydralazine etc. No single drug or technique is 
satisfactory
.
 Recommendations for attenuating the 
reflex hypertension and tachycardia are therefore 
manifold. The technique besides minimising the 
cardiovascular responses to anaesthesia for patients at 
risk must also satisfy the following requirements. 
1. It must be applicable regardless of patient’s 
collaboration. 
2. It should prevent impairment of cerebral blood flow 
and avoid arousal of the patient. 
3. It should neither be time consuming nor affect the 
duration or modality of ensuing anaesthesia. The 
present study is to evaluate the efficacy of Lornoxicam 
in attenuation of pressor response to laryngoscopy and 
intubation with minimal side effects and better 
pharmacological profile.  
 
Materials and methods 
 
 A clinical comparative study of attenuation of 
sympathetic response to laryngoscopy and intubation 
was done in 60 patients posted for elective surgery. 
Study was conducted in Gandhi Hospital, 
Secunderabad after obtaining approval of the hospital 
ethical committee and written informed consent from 
the patients. General anaesthesia was provided with 
endotracheal intubation in all patients. Patients 
undergoing various orthopaedic, ENT, Gynaecological, 
General Surgical, Neurosurgical and Laparoscopic 
procedures were selected. Following criteria’s were 
adopted for selecting patients.  
Inclusion Criteria: Patients scheduled for elective 
surgeries, Age between 20 to 50 years of both the 
sexes,  with ASA grade I or II, Mallampati airway 
assessment of grade I and II.  
Exclusion Criteria:  Those who had taken drugs that 
could influence haemodynamic and autonomic 
function. Patients with risk of pulmonary aspiration. 
Predictably difficult airways. Successful intubation 
after more than one attempt. Obesity(BMI>30) and 
patients with known allergy to NSAIDS. Patients with 
renal or hepatic dysfunction.  
Patients were selected after thorough pre-anaesthetic 
assessment and investigations. An informed consent 
was taken in all the patients. 60 cases are divided in to 
two groups 30 in each group. Group-1 was Control 
group. In this group placebo i.e (Normal saline-4ml) 
was administered 30 min before intubation. Group-2 
was Lornoxicam group. In this group patients received 
lornoxicam 16mg intravenous 30 min before intubation 
to attenuate pressor response to laryngoscopy and 
intubation. Investigations like Hb%, TC, DC and ESR, 
Fasting blood sugar, blood urea and serum creatinine, 
electrocardiogram and chest X-ray.  
Pre-medication: All the patients were visited the day 
before surgery and pre-anaesthetic counselling was 
done. All patients received Diazepam 10mg orally at 
night on the day before surgery. On the day of surgery 
intravenous line was secured with and following pre-
medications were given 45 minutes before induction. 
Inj. Midazolam 0.05mg/kg IM, Inj Tramadol 1.5-
2mg/kg IV given for analgesia before induction in both 
groups. Patients were monitored by pulse oximeter. On 
entering the operation theatre, pulse oximeter, non 
invasive blood pressure and ECG monitors were 
connected. A preinduction heart rate, systolic and 
diastolic blood pressures were recorded IV infusion of 
DNS solution was started. All the patients were 
preoxygenated with 100% oxygen for 3 minutes before 
induction. Induction was achieved with Inj. 
Thiopentone sodium 5mg/kg IV given in 2.5% 
solution. Inj. Glycopyrrolate 0.2mg IV was given along 
with Thiopentone. After induction of anaesthesia (loss 
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of eyelash reflex), heart rate, systolic and diastolic 
blood pressures were recorded. Succinylcholine was 
administered at a dose of 2mg/kg IV.  Laryngoscopy 
was done using rigid laryngoscope with standard 
Macintosh blade. Intubation was done with appropriate 
sized, disposable, high volume low pressure cuffed 
endotracheal tube. Oral intubation was done for all 
surgical procedures. Laryngoscopy and intubation was 
done within 15 to 20 seconds. Heart rate, systolic and 
diastolic blood pressure were recorded at 1,3,5,10 and 
15 minute intervals from the onset of laryngoscopy. In 
Group-1 Placebo (normal saline-4ml) was administered 
30 min before intubation. In Group-2 Lornoxicam 16 
mg was administered through intravenous route 30 min 
before intubation. 
 
Figure 1 shows diagrammatic representation of timings of administration of drugs and laryngoscopy and intubation. 
Lornoxicam Group: 
Lornoxicam 
  
           30min   25      20     15        10       5       laryngoscopy & intubation 
Control Group: 
Placebo (Normal saline) 
                 
  
         30min      25     20      15      10       5      laryngoscopy and intubation 
 
Fig 1: Diagrammatic representation of timings of administration of drugs and laryngoscopy and intubation. 
Lornoxicam Group 
 
 
Patients were connected to Bain’s circuit and 
anaesthesia was maintained with oxygen (33%), N2O 
(67%), halothane 0.5% and non depolarising muscle 
relaxant vecuronium bromide at a dose of 0.05 mg/kg 
IV and IPPV. Adequacy of ventilation was monitored 
clinically and SPO2 was maintained at 99-100%. 
Positioning, epinephrine infiltration throat packing and 
surgery were withheld till the completion of recording. 
At the end of the surgery reversal was done with inj. 
Neostigmine 0.05 mg/kg and inj.Glycopyrrolate 
0.01mg/kg IV. An observation was made related to 
adverse effects of drugs and anaesthesia related 
problems and were attended to appropriately. 
 
Results 
 
A clinical comparative study of attenuation of sympathetic response to laryngoscopy and intubatied patients posted 
for elective surgery.  
 
Table 1:  Demographic details 
 
Age Control Lornoxicam P-Value 
Minimum 18 18  
            0.1518 
 
 
Maximum 50 50 
Mean 31 28 
Standard Deviation 8 8 
Sex  
Male 14 14  
1.00 Female 16 16 
Weight 
Minimum 50 45  
            0.5548 Maximum 75 70 
Mean 59 58 
Std Deviation 7 6 
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Table 1 shows shows the age distribution in years  in control and the two study groups. The age range was 20-50 
years for control and study groups. The mean values of age with standard deviation are 31±8 and 28±8 in control 
and Lornoxicam group respectively. There was no significant difference between two groups (P- value>0.05) with 
P- value being 0.1518. In control group 46.6% were males and 53.3% were females. In Lornoxicam group also 
46.6% were males and 53.3% were females. No significant difference was observed in sex wise distribution of the 
cases between the two groups (P- value>0.05) with P- value being 1.00 calculated with Fisher’s exact test. Mean 
±SD OF weight in control group is 59±7 when compared to 58±6 in Lornoxicam group. There is no much 
significant difference of weight distribution  in two groups with P- value being 0.5548 calculated with unpaired t 
test. 
  
Table 2 : Comparison of hemodynamic variables in between two groups 
 
Variables Heart rate T-test 
Control Lornoxicam  
Mean±sd (%)diff Mean±sd (%)diff P value T value 
Baseline  
83±8 
-  
86±12 
-  
0.2592 
 
1.1393 
15 min pre-induction 86±7 3.61% 88±7.7 2.3% 0.2969 1.0527 
30 min pre-induction 87±7 4.8% 89±7.4 3.5% 0.2866 1.0754 
Post-induction 89+_8.2 7.22% 94±7.7 9.3% 0.0180 0.0180 
1 min 110±7.5 32.5% 94±7.5 9.3% <0.0001 8.2624 
3 min 102±8.2 22.8% 91±8.9 5.8% <0.0001 4.9786 
5 min 96±7 15.6% 89±7.1 3.5% 0.0003 3.8454 
10 min 90±7 8.4% 85±7.1 1.2% 0.008 2.7467 
15 min 82±7 1.2% 83±5 3.5% 0.5268 0.6367 
Systolic blood pressure 
Baseline 120±7.8 - 118±8.7 - 0.3524 0.9375 
15 min pre-induction 123±6.8 2.5% 122±8 3.4% 0.6039 0.5217 
30 min pre-induction 125±5 4.1% 123±8.27 4.2% 0.2617 1.1335 
Post-induction 123±10 2.5% 133±9.9 11.2% 0.003 3.8924 
1 min 169±15 41% 134±8.7 13.5% <0.0001 11.0553 
3 min 159±9.7 32.5% 130±5.5 10.2% <0.0001 14.2447 
5 min 147±11 22.5% 127±4.7 7.6% <0.0001 9.1577 
10 min 129±12 7.5% 122±8.9 3.4% 0.0129 2.5663 
15 min 122±8.2 1.7% 120±8.5 1.7% 0.3575 0.9275 
Diastolic blood pressure 
Baseline 78±8 - 79±9 - 0.6509 0.4549 
15 min pre-induction 79±9 1.3% 79±8.6 0.5% 1.0000 0.0000 
30 min pre-induction 80±8 2.6% 80±8 1.3% 1.0000 0.0000 
Post-induction 78±7.1 -1.15% 84±12 6.3% 0.02 2.3570 
1 min 105±8.9 34.6% 85±8.7 7.6% <0.0001 8.8017 
3 min 96±8 23% 82±7.1 3.8% <0.0001 7.1690 
5 min 90±9 15.4% 78±6.6 1.3% <0.0001 5.8891 
10 min 78±6 0.8% 76±9.4 3.8% 0.3300 0.9823 
15 min 76±8 2.6% 75±8.8 5% 0.6468 0.4605 
Mean arterial pressure 
Baseline 92±8 _ 93±8.9 _ 0.6489 0.4577 
15 min pre-induction 94±8 2.2% 92.8±7.5 0.2% 0.5513 0.5994 
30 min pre-induction 95±6 3.3% 94±7.3 1.1% 0.5644 0.5796 
Post-induction 93±7 1.1% 103±10 10.8% <0.001 4.4871 
1 min 127±8.5 38% 104±11 11.8% <0.0001 9.0621 
3 min 117±7.1 27.2% 98±5.7 5.4% <0.0001 11.4298 
 
Asian Pac. J. Health Sci., 2016; 3 (4):103-110                                           e-ISSN: 2349-0659,   p-ISSN: 2350-0964                         
____________________________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________________________
Adam and Boda               ASIAN PACIFIC JOURNAL OF HEALTH SCIENCES, 2016; 3(4): 103-110 
www.apjhs.com      107 
 
5 min 109±8.1 18.5% 94±5.5 1.07% <0.0001 8.4395 
10 min 95±6.8 3.3% 91±8.8 2.15% 0.0536 1.9700 
15 min 91±6.8 1.1% 89±8.2 4.3% 0.3081 1.0283 
 
At 10 min there was significant difference in heart rate 
with P- value being 0.008. The heart rate at the end of  
15 min was not significantly higher when compared to 
pre induction values.At 15
th
 minute there is no much 
significant difference with P-value being 0.35. 
Maximum increase in systolic blood pressure at 1min 
after intubation with 41% increase in control group 
when compared to 13.5% in lornoxicam group. It is 
statistically very significant with P-value 
being(<0.001). These differences in systolic blood 
pressure between control group and lornoxicam group 
remains statistically very significant at all times except 
at 15th minute where it is statistically insignificant. At 
1 and 3 min post laryngoscopy  the difference is very 
highly significant (P <0.001).Changes in diastolic 
blood pressure assessed pre and post induction and at 
various time intervals between control and study 
groups is presented.. Maximum increase in mean 
arterial  pressure at 1min after intubation with 38% 
increase in control group when compared to 11.8% in 
Lornoxicam group. It is statistically very significant 
with P-value being(<0.0001). These differences in 
mean arterial pressure between control group and 
lornoxicam group remains statistically very significant 
at all times except at 15th minute where it is 
statistically insignificant and at 10
th
 min where it is 
slightly insignificant. 
 
Table 3: Comparison of rate pressure product (in mm of Hg*bpm) in between the groups 
 
 Rate pressure product T-test 
Control Lornoxicam  
Mean±sd (%)diff Mean±sd (%)diff P value T value 
Baseline 10047±1432 _ 10429±1532 _ 0.3226 0.9977 
15min preinduction 10579±1297 5.3% 10674±1332 2.34% 0.7806 0.2799 
30min preinduction 10966±1122 9.14% 11016±1316 5.6% 0.8772 0.1553 
Post-induction 10983±1348 9.3% 12564±1517 20.5% <0.001 4.2671 
1 min 18870±1943 87% 12761±1381 22.4% <0.0001 14.0367 
3 min 16355±1570 62.7% 11735±1289 12.5% <0.0001 12.4571 
5 min 14189±1655 41.2% 11314±970.6 8.5% <0.0001 8.2075 
10 min 11564±1619 15% 10357±984.4 0.7% 0.0009 3.4891 
15 min 10052±1088 0.05% 10026±847.3 3.9% 0.9181 0.1033 
 
Shows differences in rate pressure product at pre 
induction, post-induction and at various time intervals 
from the onset of laryngoscopy in control and study 
groups are presented. The difference in the rate 
pressure product between control and Lornoxicam 
groups remain significant at immediately after 
laryngoscopy and intubation and at 1min,3min and 5 
min with P-value being(<0.0001) and at 10
th
 minute 
where the P-value being 0.0009. At 15
th
 minute there is 
no much significant difference with P-value being 
0.918. Maximum increase in rate pressure product at 
1min after intubation with 87% increase in control 
group when compared to 22.4% in Lornoxicam group. 
It is statistically very significant with P-value 
being(<0.0001). These differences in rate pressure 
product between control group and Lornoxicam group 
remains statistically very significant at all times except 
at 15th minute where it is statistically insignificant. 
 
Discussion 
 
 The sequence of induction of anaesthesia, 
laryngoscopy and tracheal intubation are associated 
with marked haemodynamic changes and autonomic 
reflex activity which may be a cause of concern in 
many high risk patients. Laryngoscopy and intubation 
is associated with rise in heart rate, blood pressure and 
incidence of cardiac arrhythmias. These potentially 
dangerous changes disappear within 5 minutes of onset 
of laryngoscopy[6]. Although these responses of blood 
pressure and heart rate are transient and short lived 
they may prove to be detrimental in high risk patients 
especially in those with cardiovascular disease, 
increased intracranial pressure or anomalies of the 
cerebral blood vessels. An average rise in mean arterial 
pressure of 25mm Hg and 47.7 mmHg have been 
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documented. An increase in mean arterial pressure of 
26.5 mm Hg and 20 to 40 torr when compared with 
awake control levels and 35 to 60 torr when compared 
with preintubation values[7,8]have been reported after 
placement of an endotracheal tube. A rise in mean 
heart rate of 29.9 beats/min has also been noted[15]. 
Many factors influence the cardiovascular changes 
associated with laryngoscopy and intubation. Age, 
drugs, type and duration of procedures, depth of 
anaesthesia, hypoxia, hypercarbia etc., influence the 
pressor response. Variations of heart rate changes 
decrease with increasing age. Young patients show 
more extreme changes. Marked fluctuations in 
haemodynamic responses are often seen in geriatric 
patients. In our study we selected the optimal age range 
of 18 to 50 years. Bachofen M[10] stated the criteria 
for selection appropriate drug to prevent sympathetic 
response. The drug must be applicable regardless of 
patient collaboration, prevent impairment of cerebral 
blood flow and avoid arousal of the patients. It should 
neither be time consuming nor affect the duration and 
modality of ensuing anaesthesia. Intravenous 
Lornoxicam is found to fulfill the above criteria. 
Lornoxicam is a NonSteroidal Anti-Inflammatory Drug 
(NSAID) that belongs chemically to the oxicams and 
has been successfully used as a perioperative analgesic 
agent with a better safety profile regarding renal and 
hepatic function tests, in addition to better 
gastrointestinal tract tolerability compared to selective 
COX-  2inhibitors. There are very few studies done 
using Lornoxicam in attenuating haemodynamic 
changes seen with laryngoscopy and intubation. Hence 
the need for this study to evaluate the efficacy of 
intravenous Lornoxicam in attenuating pressor 
response to laryngoscopy and intubation. Lornoxicam 
has been used successfully to treat post operative pain. 
It was reported that intravenous 8mg was equianalgesic 
with 20mg of morphine,50mg of pethidine and 
intravenous 16mg is superior to the analgesic potency 
of 100mg tramadol and is comparable to 100 
micrograms fentanyl to relieve pain in day care 
surgeries. The study entitled “Effect of 
haemodynamic response to laryngoscopy and 
endotracheal  intubation with intravenous 
lornoxicam-a double blinded control study” was 
undertaken in GANDHI HOSPITAL 
,SECUNDERABAD after obtaining approval of ethics 
committee of hospital and written informed consent to 
evaluate the efficacy of Lornoxicam in attenuating 
pressor response to laryngoscopy and intubation. After 
taking written informed consent 60 patients who 
belong to ASA -I &ASA-II between age groups 20-
50yrs were randomly allocated in to two groups. 
GROUP –A:  Is the control group who received 5ml of 
normal saline as placebo. GROUP-B:  Is the group who 
received intravenous Lornoxicam. This is a double 
blind study and both the drug and placebo are given 30 
min before induction of Anaesthesia and intubation. 
After giving the drug haemodynamic parameters are 
measure every 15 min before intubation and 
immediately after intubation and 1,3,5,10,15 minutes 
there after. Changes seen in haemodynamic parameters 
are statistically compared between two groups. The 
hypothesis made before study is, Laryngoscopy and 
Intubation causes marked stress response caused 
because of release of catecholamines which is the  
cause of morbidity and mortality in patients who are 
chronically hypertensives or the patients with 
compromised cardiorespiratory reserve[11,12]. Hence 
to attenuate this response many drugs have been 
studied and in use. Lornoxicam is one such drug which 
has minimal side effects and wide margin of safety 
which is found to attenuate the pressor response to 
laryngoscopy and intubation.  
Demographic Profile: Demographic data comparing 
age, sex, weight shows no statistically significant 
difference among both the groups and has been 
compared with other studies.  
Age: In present study mean age group of Lornoxicam 
and control group was 28±8 and 31±8 respectively 
which was comparable to the study conducted by 
M.Daabiss M.Hashish
 
(2010) in which the mean age 
group of Lornoxicam and control group was 33.1±4.4 
and 31.5±5.6 respectively.  
Sex: In present study the sex ratio is 16:14 in both the 
groups which is coming to 53.3% females and 46.6% 
males. In the study conducted by M.Daabiss et 
al[8](2010) the total number of patients taken are 50 
among which the sex ratio(female:male) is 12:13 in 
lornoxicam group i.e.48% females and 52% males and 
in control group the ratio is 10:15 which comes to 40% 
females and 60% males which shows that the sex 
distribution is comparable to the present study.  
Weight Distribution: In present study weight 
distribution in kg in Lornoxicam group is 58±6 and in 
control group it is 59±7.In the study conducted by 
M.Dabiss etal.
8 
the weight distribution in Lornoxicam 
and control group is 66.9±6.7 and 69.7±4.2 
respectively.  
Heart Rate: In the present study baseline heart rates 
were 83±8 and 86±2 in control group and Lornoxicam 
group respectively. Maximum increase in heart rate 
was observed at 1min post intubation in control group 
with 32.5% increase when compared to 9.3% in 
Lornoxicam group with P-value being <0.0001. Pvalue 
was found to be significant(<0.05) at post induction  
3min ,5min and 10min after intubation. In the study 
conducted by M.Daabiss and M Hashish(2010) in 
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which 50 patients were scheduled for general 
anaesthesia the baseline heart rates were recorded and 
heart rates were compared  at 0,1,2,3 min up to 10min 
every minute  after intubation between control group 
and Lornoxicam group with P-value being 0.000, 
0.000, 0.019, 0.036 respectively at 0,1,2,3 min which 
was found to be significant. In another study conducted 
by W.Raid and A.Moussa[13](2008)
  
in which 50 
patients who were scheduled for general anaesthesia 
were taken to evaluate the efficacy of 
Lornoxicam(8mg) in attenuation of intubation response 
in placebo(saline) controlled study where parameters 
taken were heart rate, SBP, DBP, MAP at baseline, 
post induction,1min, 3min, 5min, 10min after 
intubation, significant increase in heart rates have been 
found in control group when compared to Lornoxicam 
group at 1,3,5,10 min with significant  P- value being 
<0.05. Systolic Blood Pressure: In our present study 
baseline systolic blood pressure was found to be 
120±7.8 and 118±8.7 in control group and Lornoxicam 
group respectively. Immediate post induction systolic 
blood pressures were found to be 133±9.9 in control 
group when compared to 123±10 in Lornoxicam with 
P-value being 0.003 which was significant. Maximum 
increase in systolic blood pressure was found at 1min 
after intubation with 41% increase in control group 
when compared to 13.5% increase in Lornoxicam 
group with P- value being <0.0001 which is very 
significant. Significant difference in systolic blood 
pressure was found at 3min,5min and 10min with P- 
value being <0.0001, <0.0001 and 0.012 respectively. 
In the study conducted by M Daabiss and M 
Hashish(2010) there was significant difference in 
systolic blood pressure in Lornoxicam group when 
compared to control group(saline group) at 0min, 1min, 
2min, 3min, after intubation with P-value being 0.0001, 
0.005, 0.014, 0.037 respectively. Though the study was 
conducted up to 10min, as the values were not 
mentioned in the original article they were not 
mentioned in the above table. In another study 
conducted by W Raid and A Moussa[13](2010)  
systolic blood pressure was found to be significantly 
elevated in control group when compared to 
Lornoxicam group at 1min, 3min, 5min and 10 min 
after intubation with P-value being <0.05. In another 
study conducted by Soliman, W.R Moussa, et 
al[14](2007) on preoperative Lornoxicam attenuating 
haemodynamic response to intubation on 50 patients of 
elderly age group significant increase in systolic blood 
pressure has been observed in control group when 
compared to Lornoxicam group at 
1min,3min,5min,10min after intubation with P-value 
being(<0.05).  
Diastolic Blood Pressure: In the present study 
baseline diastolic blood pressures were 78±8 and 79±9 
in control group and Lornoxicam group respectively. 
Maximum increase in diastolic blood pressure was 
found at 1min after intubation in control group when 
compared to Lornoxicam group with 34.6% increase in 
control group when compared to 7.6% increase in 
Lornoxicam group with P-value being <0.0001. 
Significant difference in diastolic blood pressure was 
observed at immediate post induction and at 3min, 
5min with P-value being 0.02, <0.0001, <0.0001 
respectively. At 10min and 15 min no significant 
difference was found in two groups. In the study 
conducted by M Daabiss and M Hashish (2010) 
significant difference diastolic blood pressure was 
found in control group when compared to Lornoxicam 
group at 0min, 1min, 2min, 3min with p value being 
0.000, 0.007, 0.02, 0.043 respectively. In the another 
study conducted by W.Raid and A.Moussa (2008)in 
50 patients  significant difference in diastolic blood 
pressure was found in control group when compared to 
Lornoxicam group at immediate postinduction, 1min, 
3min, 5min, 10min with p value being <0.05.  In 
another study conducted by Soliman, W.R ; Moussa 
et al 
 
(2007) significant difference in diastolic blood 
pressure has been observed at 1min, 3min, 5min, 10 
min post intubation with P-values being <0.05 between 
control group and Lornoxicam group. Mean Arterial 
Pressure: In the present study baseline mean arterial 
pressures were found to be 92±8 and 93±8.9 in control 
group and Lornoxicam group respectively. Significant 
increase in mean arterial pressures was found at 
immediate postinduction with p value being <0.001. 
Maximum increase in mean arterial pressures were 
found at 1min after intubation with increase of 38% in 
control group when compared to 11.8% in Lornoxicam 
group with P- value being <0.0001. Significant 
difference was found at 3min and 5min after intubation 
with p value being <0.0001 and <0.0001 respectively. 
At 10 th minute difference was slightly insignificant 
with P- value being 0.0536. At 15 min no significant 
difference in mean arterial pressure was found in 
control group when compared to Lornoxicam group. In 
the study conducted by M Daabiss and M 
Hashish(2010) P- value immediately postinduction 
was found to be 0.055. Significant increase in mean 
arterial pressures in control group when compared to 
Lornoxicam group was found at 0min, 1min, 2min, 
3min after intubation with P- value being 0.000, 0.008, 
0.024 respectively. In another study conducted by W 
Raid and A Moussa[13](2008)significant increase in 
mean arterial pressures in control group when 
compared to Lornoxicam group was found at 1min, 
3min, 5min,10min with p value being <0.05. In another 
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study conducted by Soliman.W.R; Moussa A et 
al[14](2007)in elderly significant increase in mean 
arterial pressures in control group when compared to 
Lornoxicam group was observed at 1,3.5.10 min with 
P- value being <0.05.  
Rate Pressure Product: In the present study 
maximum increase in rate pressure product which is 
the product of systolic blood pressure and heart rate  in 
both groups was at: GROUP-A (control): A maximum 
increase of 87% was observed in rate pressure product 
at 1min after laryngoscopy and intubation. GROUP-B 
(Lornoxicam): A maximum increase of 22.4% was 
observed at 1min after intubation which is comparable 
to control group with p-value showing significance. 
Immediate postinduction significant difference in rate 
pressure product has been observed with p value being 
<0.001. Significant increase in rate pressure product 
has been observed in control group when compared to 
Lornoxicam group at 3min, 5min and at 10 min with p 
value being <0.0001, <0.0001, 0.0009 respectively. At 
15
th
 min no significant difference has been found with 
p value being 0.9181. The present study observation 
has been supported by study conducted by M Daabiss 
and M Hashish
8
 who have observed significant 
increase in rate pressure product in control group when 
compared to Lornoxicam group at 0min, 1min, 2min 
and 3min after intubation with p value being <0.05.  
 
Conclusion 
 
Based on the present clinical comparative study the 
following conclusions can be made: In patients with no 
drugs to attenuate the sympathetic response to 
laryngoscopy 
and intubation the maximum raise in heart rate, 
systolic, diastolic and mean arterial blood pressures 
were statistically and clinically very highly significant 
and can be detrimental in high risk patients. 
Lornoxicam  significantly attenuates the sympathetic 
response to laryngoscopy and tracheal intubation. 
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